Genedata Opens Subsidiary in Tokyo
Japan is becoming an important global player in pharmaceutical research and development. Over the past few years, major Japanese pharmaceutical companies have expanded their research activities in the Asia region and beyond. According to Genedata, this has created demand for enterprise-level computational solutions for life sciences and drug discovery research. Genedata KK aims to satisfy this demand and to enable expansion of the company's existing collaborations in Japan.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.